Detalles de la búsqueda
1.
Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial.
Haematologica
; 104(11): 2274-2282, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30923094
2.
Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trial.
Genes Chromosomes Cancer
; 56(7): 524-534, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28236351
3.
Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial.
Haematologica
; 99(1): 148-54, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23996482
4.
Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation-a phase I/II study.
Leukemia
; 34(3): 831-844, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31624377
5.
Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene.
Blood
; 109(9): 4089-96, 2007 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17234742
6.
Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer.
Blood
; 107(12): 4954-60, 2006 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16497972
7.
The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients.
Blood
; 103(8): 2908-13, 2004 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15070662
Resultados
1 -
7
de 7
1
Próxima >
>>